SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38,65
11-февраля-25 16:45:00
15 мин. задержка
Акции
+0,72
+1,90%
Сегодняшний диапазон
37,66 - 38,66
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
19 авг 2024 07:00:51 Источник Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2024 Financial Results
06 авг 2024 16:06:00 Источник Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01 авг 2024 16:30:11 Источник Nasdaq GlobeNewswire
-
23 июл 2024 16:13:37 Источник Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
30 май 2024 16:25:33 Источник Nasdaq GlobeNewswire
-
23 май 2024 16:05:48 Источник Nasdaq GlobeNewswire
-
09 май 2024 16:05:39 Источник Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2024 Financial Results
08 май 2024 16:05:50 Источник Nasdaq GlobeNewswire
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01 май 2024 08:00:32 Источник Nasdaq GlobeNewswire
-
24 апр 2024 16:05:53 Источник Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update for SPN-830
08 апр 2024 08:00:16 Источник Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
06 мар 2024 16:30:50 Источник Nasdaq GlobeNewswire
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 фев 2024 16:30:04 Источник Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 фев 2024 16:05:33 Источник Nasdaq GlobeNewswire
-
13 фев 2024 16:05:20 Источник Nasdaq GlobeNewswire
-
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
05 фев 2024 08:30:39 Источник Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2023 Financial Results
08 ноя 2023 16:05:44 Источник Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies London Healthcare Conference
07 ноя 2023 16:30:42 Источник Nasdaq GlobeNewswire
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
02 ноя 2023 07:00:05 Источник Nasdaq GlobeNewswire
-
25 окт 2023 16:15:32 Источник Nasdaq GlobeNewswire